Troy C. Quigg

1.4k total citations
18 papers, 252 citations indexed

About

Troy C. Quigg is a scholar working on Infectious Diseases, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Troy C. Quigg has authored 18 papers receiving a total of 252 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Hematology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Troy C. Quigg's work include Hematopoietic Stem Cell Transplantation (5 papers), Acute Lymphoblastic Leukemia research (4 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Troy C. Quigg is often cited by papers focused on Hematopoietic Stem Cell Transplantation (5 papers), Acute Lymphoblastic Leukemia research (4 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Troy C. Quigg collaborates with scholars based in United States, Canada and Norway. Troy C. Quigg's co-authors include Annie Cheng, Susan E. Prockop, Eneida R. Nemecek, Elizabeth Burke, Sonali Chaudhury, Paul A. Carpenter, Jack Hayes, Joanne Kurtzberg, Vinod K. Prasad and Donna Skerrett and has published in prestigious journals such as Blood, Frontiers in Immunology and Clinical Pharmacology & Therapeutics.

In The Last Decade

Troy C. Quigg

16 papers receiving 245 citations

Peers

Troy C. Quigg

GENET

HEMAT

SURGE

Gaurav Kharya India

Jasmita Dass India

Becky Manes United States

Ramya Uppuluri India

Alexandra Kolenová Slovakia

Ioannis Politikos United States

Smeeta Gajendra India

Canan Uçar Türkiye

Victor Aquino United States

Muriel Picard France

Gaurav Kharya India

Troy C. Quigg

67 ×0.7

GENET

109 ×1.6

HEMAT

64 ×1.2

35 ×0.8

SURGE

41 ×0.9

Citations per year, relative to Troy C. Quigg Troy C. Quigg (= 1×) peers Gaurav Kharya

Countries citing papers authored by Troy C. Quigg

Since Specialization

Citations

This map shows the geographic impact of Troy C. Quigg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Troy C. Quigg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Troy C. Quigg more than expected).

Fields of papers citing papers by Troy C. Quigg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Troy C. Quigg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Troy C. Quigg. The network helps show where Troy C. Quigg may publish in the future.

Co-authorship network of co-authors of Troy C. Quigg

This figure shows the co-authorship network connecting the top 25 collaborators of Troy C. Quigg. A scholar is included among the top collaborators of Troy C. Quigg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Troy C. Quigg. Troy C. Quigg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Hartog, Nicholas, et al.. (2024). 182 Inherited POMP-Related Autoinflammation and Immune Dysregulation Disease Treated with Baricitinib Prior to Hematopoietic Stem Cell Transplant. Clinical Immunology. 262. 110124–110124.

Li, Amanda M., Catherine Aftandilian, Susan I. Colace, et al.. (2024). A Retrospective Study of Inotuzumab Ozogamicin in Individuals with Down Syndrome and B-Cell Acute Lymphoblastic Leukemia. Blood. 144(Supplement 1). 4204–4204.

Capitini, Christian M., Amy Moskop, Anant Vatsayan, et al.. (2024). Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomas. Blood Advances. 8(15). 4164–4168. 2 indexed citations

Pfeiffer, Thomas, Stephanie Hyde, Shalini Shenoy, et al.. (2024). Alemtuzumab, Fludarabine, Melphalan, and Thiotepa As Reduced-Intensity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation in Inborn Errors of Immunity. Blood. 144(Supplement 1). 375–375. 1 indexed citations

Matheny, Christina, et al.. (2021). Parvovirus B19‐associated graft failure after allogeneic hematopoietic stem cell transplantation. Cancer Reports. 5(1). e1403–e1403. 8 indexed citations

Kurtzberg, Joanne, Hisham Abdel‐Azim, Paul A. Carpenter, et al.. (2020). A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 26(5). 845–854. 117 indexed citations

Matheny, Christina, et al.. (2020). Enteral Vancomycin Is Effective Clostridium Difficile prophylaxis in Pediatric, Adolescent, and Young Adult Hematopoietic Stem Cell Transplant Recipients. Biology of Blood and Marrow Transplantation. 26(3). S143–S143. 1 indexed citations

Matheny, Christina, et al.. (2020). Parvovirus B19-Associated Graft Failure after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 26(3). S344–S344. 2 indexed citations

Eckrich, Michael J., et al.. (2018). Reduced-Intensity Allogeneic Stem Cell Transplant for Sickle Cell Disease in Pediatrics: A Single Institution Experience. Biology of Blood and Marrow Transplantation. 24(3). S434–S435. 1 indexed citations

10.

Chinn, Iván K., Robert P. Sanders, Asbjørg Stray‐Pedersen, et al.. (2017). Novel Combined Immune Deficiency and Radiation Sensitivity Blended Phenotype in an Adult with Biallelic Variations in ZAP70 and RNF168. Frontiers in Immunology. 8. 576–576. 19 indexed citations

11.

Hege, Kerry, Troy C. Quigg, & David Delgado. (2015). Alemtuzumab, Fludarabine, Low‐Dose TBI, and Double Umbilical Cord Transplant for Primary Graft Failure in a Patient with Recurrent HLH. Pediatric Blood & Cancer. 63(2). 361–363. 4 indexed citations

12.

Metzger, Ingrid F., Troy C. Quigg, John T. Callaghan, et al.. (2014). Substantial Effect of Efavirenz Monotherapy on Bilirubin Levels in Healthy Volunteers. Current Therapeutic Research. 76. 64–69. 12 indexed citations

13.

Trimble, R. M., Jane T. Atkins, Troy C. Quigg, et al.. (2014). Vaccine-associated paralytic poliomyelitis and BCG-osis in an immigrant child with severe combined immunodeficiency syndrome - Texas, 2013.. PubMed. 63(33). 721–4. 11 indexed citations

14.

Quigg, Troy C., et al.. (2014). Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Outcomes for Juvenile Myelomonocytic Leukemia (JMML), a 15-Year Single Center Experience. Biology of Blood and Marrow Transplantation. 20(2). S180–S180. 1 indexed citations

15.

Quigg, Troy C., et al.. (2013). Ages and Stages Questionnaires-3 Developmental Screening of Infants and Young Children With Cancer. Journal of Pediatric Oncology Nursing. 30(5). 235–241. 14 indexed citations

16.

Michaud, Véronique, et al.. (2012). Induction of CYP2C19 and CYP3A Activity Following Repeated Administration of Efavirenz in Healthy Volunteers. Clinical Pharmacology & Therapeutics. 91(3). 475–482. 35 indexed citations

17.

Quigg, Troy C., et al.. (2012). Lung Function Before and After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation. Journal of Pediatric Hematology/Oncology. 34(4). 304–309. 18 indexed citations

18.

Quigg, Troy C., Nadine Haddad, Jeffrey C. Buchsbaum, & Chie‐Schin Shih. (2011). Hypothalamic obesity syndrome: Rare presentation of CNS+ B‐cell lymphoblastic lymphoma. Pediatric Blood & Cancer. 59(5). 930–933. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact